Research and Markets: Amyotrophic Lateral Sclerosis Pipeline Highlights - 2014 Update

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/zw5hrg/amyotrophic) has announced the addition of the "Amyotrophic Lateral Sclerosis Pipeline Highlights - 2014 Update" report to their offering.

The latest report Amyotrophic Lateral Sclerosis Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Amyotrophic Lateral Sclerosis market. It covers emerging therapies for Amyotrophic Lateral Sclerosis in active clinical development stages including early and late stage clinical trials.

The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Amyotrophic Lateral Sclerosis pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Amyotrophic Lateral Sclerosis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Amyotrophic Lateral Sclerosis pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which Amyotrophic Lateral Sclerosis pipeline products will be launched in the US and Ex-US till 2017.

Key Topics Covered:

1. Amyotrophic Lateral Sclerosis Pipeline by Stages

2. Amyotrophic Lateral Sclerosis Pipeline by Drug Class

3. Amyotrophic Lateral Sclerosis Pipeline by Company

4. Amyotrophic Lateral Sclerosis Phase 3 Clinical Trial Insights

5. Amyotrophic Lateral Sclerosis Phase 2 Clinical Trial Insights

6. Amyotrophic Lateral Sclerosis Phase 1 Clinical Trial Insights

7. Amyotrophic Lateral Sclerosis Preclinical Research Insights

8. Amyotrophic Lateral Sclerosis Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information visit http://www.researchandmarkets.com/research/zw5hrg/amyotrophic.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals